550 related articles for article (PubMed ID: 8826812)
1. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.
Lennette ET; Blackbourn DJ; Levy JA
Lancet; 1996 Sep; 348(9031):858-61. PubMed ID: 8826812
[TBL] [Abstract][Full Text] [Related]
2. Sexual transmission and the natural history of human herpesvirus 8 infection.
Martin JN; Ganem DE; Osmond DH; Page-Shafer KA; Macrae D; Kedes DH
N Engl J Med; 1998 Apr; 338(14):948-54. PubMed ID: 9521982
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections.
Rezza G; Lennette ET; Giuliani M; Pezzotti P; Caprilli F; Monini P; Buttò S; Lodi G; Di Carlo A; Levy JA; Ensoli B
Int J Cancer; 1998 Jul; 77(3):361-5. PubMed ID: 9663596
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women.
Kedes DH; Ganem D; Ameli N; Bacchetti P; Greenblatt R
JAMA; 1997 Feb; 277(6):478-81. PubMed ID: 9020272
[TBL] [Abstract][Full Text] [Related]
5. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
[TBL] [Abstract][Full Text] [Related]
6. High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population.
Feiterna-Sperling C; Königs C; Notheis G; Buchholz B; Krüger R; Weizsäcker K; Eberle J; Hanhoff N; Gärtner B; Heider H; Krüger DH; Hofmann J
Med Microbiol Immunol; 2016 Oct; 205(5):425-34. PubMed ID: 27240652
[TBL] [Abstract][Full Text] [Related]
7. Human herpesvirus-8 (HHV-8) antibodies in women from São Paulo, Brazil. Association with behavioral factors and Kaposi's sarcoma.
Caterino-De-Araujo A; de los Santos-Fortuna E; Carbone PH; Cibella SE; Moreira AA
Braz J Infect Dis; 2003 Dec; 7(6):395-401. PubMed ID: 14636479
[TBL] [Abstract][Full Text] [Related]
8. Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma.
Cattani P; Capuano M; Cerimele F; La Parola IL; Santangelo R; Masini C; Cerimele D; Fadda G
J Clin Microbiol; 1999 Apr; 37(4):1150-3. PubMed ID: 10074540
[TBL] [Abstract][Full Text] [Related]
9. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population.
Plancoulaine S; Abel L; van Beveren M; Trégouët DA; Joubert M; Tortevoye P; de Thé G; Gessain A
Lancet; 2000 Sep; 356(9235):1062-5. PubMed ID: 11009141
[TBL] [Abstract][Full Text] [Related]
10. Human herpesvirus 8 infection and Kaposi's sarcoma among human immunodeficiency virus-infected and -uninfected women.
Greenblatt RM; Jacobson LP; Levine AM; Melnick S; Anastos K; Cohen M; DeHovitz J; Young MA; Burns D; Miotti P; Koelle DM
J Infect Dis; 2001 Apr; 183(7):1130-4. PubMed ID: 11237842
[TBL] [Abstract][Full Text] [Related]
11. Respective roles of serological status and blood specific antihuman herpesvirus 8 antibody levels in human herpesvirus 8 intrafamilial transmission in a highly endemic area.
Plancoulaine S; Abel L; Trégouët D; Duprez R; van Beveren M; Tortevoye P; Froment A; Gessain A
Cancer Res; 2004 Dec; 64(23):8782-7. PubMed ID: 15574792
[TBL] [Abstract][Full Text] [Related]
12. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs.
Chandran B; Smith MS; Koelle DM; Corey L; Horvat R; Goldstein E
Virology; 1998 Mar; 243(1):208-17. PubMed ID: 9527930
[TBL] [Abstract][Full Text] [Related]
13. Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang, China.
He F; Wang X; He B; Feng Z; Lu X; Zhang Y; Zhao S; Lin R; Hui Y; Bao Y; Zhang Z; Wen H
J Med Virol; 2007 Feb; 79(2):161-6. PubMed ID: 17177299
[TBL] [Abstract][Full Text] [Related]
14. Comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi's sarcoma.
Martro E; Bulterys M; Stewart JA; Spira TJ; Cannon MJ; Thacher TD; Bruns R; Pellett PE; Dollard SC
J Med Virol; 2004 Jan; 72(1):126-31. PubMed ID: 14635020
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease.
Mohanna S; Maco V; Bravo F; Gotuzzo E
Int J Infect Dis; 2005 Sep; 9(5):239-50. PubMed ID: 16095940
[TBL] [Abstract][Full Text] [Related]
16. Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission.
Whitby D; Luppi M; Sabin C; Barozzi P; Di Biase AR; Balli F; Cucci F; Weiss RA; Boshoff C; Torelli G
Br J Cancer; 2000 Feb; 82(3):702-4. PubMed ID: 10682685
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.
Wojcicki JM; Newton R; Urban MI; Stein L; Hale M; Patel M; Ruff P; Sur R; Bourboulia D; Sitas F
BMC Infect Dis; 2003 Sep; 3():21. PubMed ID: 12971827
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the frequency of antibody and titers against human herpesvirus 8 latent and lytic antigens in "at-risk" individuals and among patients with Kaposi's sarcoma.
Magri MC; Carbone PH; de los Santos-Fortuna E; Caterino-de-Araujo A
J Med Virol; 2009 Jul; 81(7):1292-7. PubMed ID: 19475629
[TBL] [Abstract][Full Text] [Related]
19. Patterns of antibodies against latent and lytic antigens of human herpesvirus 8 in an endemic population and patients with Kaposi's sarcoma in Mozambique.
Caterino-de-Araujo A; Magri MC; Manuel RC
J Med Virol; 2010 Sep; 82(9):1576-81. PubMed ID: 20648612
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
Simpson GR; Schulz TF; Whitby D; Cook PM; Boshoff C; Rainbow L; Howard MR; Gao SJ; Bohenzky RA; Simmonds P; Lee C; de Ruiter A; Hatzakis A; Tedder RS; Weller IV; Weiss RA; Moore PS
Lancet; 1996 Oct; 348(9035):1133-8. PubMed ID: 8888167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
